Fall 2025 Medical Summit

 

Date & Time	Speaker	Presentation
October 24, 2025 10:00am – 10:45am	Naomi Litchfield  Director, Patient Advocacy Bionical Emas	"Why is Early Access Important to the Breast Cancer Community" Early access is a lifeline for the breast cancer community—delivering faster diagnoses, life-saving treatments, and greater survival odds. It means catching cancer when it’s most curable, easing the burden of harsh therapies, and giving every patient a fighting chance.
10:45am – 11:30am	Jose Pablo Leone, PhD Director, Program for Breast Cancer in Men Assistant Professor of Medicine, Harvard Medical School / Dana-Farber Cancer Institute	"Update on the ETHAN Clinical Trial"  The ETHAN Clinical Trial at Dana-Farber Cancer Institute advances groundbreaking research for breast cancer in men, addressing a critical gap in oncology. This program explores tailored treatments, improves understanding of male-specific disease patterns, and paves the way for targeted, life-saving therapies.
11:30am – 11:45am	BREAK
11:45am – 12:30pm	Robert Bard, MD Medical Director of Bard Diagnostics	"Image Guided Treatment of Male Breast Cancer Tumors" Revolutionizing male breast cancer care—image guidance pinpoints tumors with precision, attacking cancer while protecting healthy tissue. This cutting-edge approach means fewer side effects, greater accuracy, and a powerful step toward personalized therapies that give men stronger outcomes and renewed hope for survival.
12:30pm – 1:15pm	Charlotte Bayala -  Host of The Cancer Caregiver Podcast, Corporate Caregiver Wellness Program Designer, Speaker	"Before the Results: How to Stay Grounded When You Can’t Know What’s Coming" This thoughtful tour offers caregivers guidance on staying grounded amid uncertainty. Drawing from the cancer journey, it highlights resilience, presence, and self-care strategies—empowering caregivers to navigate the unknown with steadiness, compassion, and strength while supporting loved ones through unpredictable challenges.
1:15pm – 2:00pm	Erling Donnelly Vice President, US Breast Cancer Franchise & Portfolio Marketing Lead, Pfizer	"Pfizer’s use of Real World Evidence to support the expansion of Ibrance for use in males and a look ahead." In today’s advancing cancer landscape, Pfizer’s use of Real World Evidence (RWE) is reshaping access to Ibrance for men with breast cancer. Attendees will discover its regulatory impact, clinical significance, and the forward-looking role of RWE in transforming oncology therapies.
2:00pm – 2:15pm	BREAK

2:15pm – 3:00pm	Dr. Leslie Waltke Physical therapist with a clinical mastery in cancer rehabilitation, Founder of the Waltke Cancer Rehabilitation Academy	"The Male Breast Cancer Rehab Plan: easing side effects, minimizing risks and getting strong again" This presentation showcases how image-guided therapy is transforming male breast cancer care—bringing unmatched precision, targeted tumor control, and reduced side effects. Attendees will discover how this innovation drives personalized treatment, improves survival, and offers new hope for men battling breast cancer.
3:00pm – 3:45pm	Dr. Barbara Bartlik Integrative Psychiatrist	"The Emotional Impact of Male Breast Cancer and its Treatment: Comprehensive Solutions to an Overlooked Problem" Male breast cancer carries profound emotional challenges that remain largely unrecognized in healthcare. Exploring the psychological toll of diagnosis and treatment, this session highlights comprehensive strategies—mental health care, family support, and integrative approaches—to foster resilience, healing, and improved quality of life.

 

October 25, 2025 

10:00am – 10:45am	Fatima Cardoso, MD, MSc, FESMO Senior Consultant, Medical Oncology President ABC Global Alliance	"Management of Advanced/Metastatic Breast Cancer in Male Patients" In today’s evolving landscape of cancer care, men with advanced or metastatic breast cancer face unique challenges often overshadowed by female-focused research. Dr. Fatima Cardoso delivers groundbreaking strategies in management, therapies, and compassionate care to transform outcomes and advance male-specific oncology.
10:45am – 11:30am	Ellen Schupper Executive Director - ABCD – After Breast Cancer Diagnosis	"The Role of Male Breast Cancer Mentors" Amid growing recognition of male breast cancer, mentorship emerges as a lifeline of hope. Ellen Schupper explores how trained peer mentors empower men with guidance, emotional support, and shared experience—bridging isolation and fostering resilience through every stage of diagnosis and survivorship.
11:30am – 11:50am	BREAK
12:00pm – 12:45pm	Don Dizon, MD Jane F. Desforges Chair in Hematology and Oncology and Professor of Medicine, Tufts University| Chief, Hematology and Oncology Service Line, Tufts Medicine	"Thriving and Palliative Care; What it is and is Not" In an era redefining survivorship, thriving with cancer requires clarity on palliative care’s true purpose. Dr. Don Dizon challenges misconceptions, illustrating how palliative care empowers patients—enhancing quality of life, dignity, and resilience while advancing beyond outdated views of end-of-life treatment.

 

12:25pm – 1:30pm	Ben Park, MD Benjamin F. Byrd, Jr. Chair in Oncology Director, Vanderbilt-Ingram Cancer Center, Professor of Medicine Vanderbilt University Medical Center	"Circulating Tumor DNA in Early Stage Breast Cancer; Breast Friends Don’t Keep Secrets" As precision medicine reshapes oncology, circulating tumor DNA offers powerful insight into early-stage breast cancer. This session reveals how ctDNA testing uncovers hidden disease, guides treatment decisions, and transforms transparency in care—proving that breast friends don’t keep secrets when survival is at stake.
1:30pm -2:15pm	Angela Mazza, DO  Triple board-certified in Endocrinology, Diabetes and Metabolism, Internal Medicine, and Anti-aging and Regenerative Medicine	"Hormones and Male Cancers" In the evolving fight against men’s cancers, hormones play a pivotal yet often misunderstood role. Dr. Angela Mazza unpacks the endocrine influences driving cancer risk and progression, offering groundbreaking insights that bridge prevention, precision treatment, and regenerative approaches for improved outcomes.